Martin Huber
Corporate Officer/Principal bei NAUTILUS BIOTECHNOLOGY, INC.
Aktive Positionen von Martin Huber
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| NAUTILUS BIOTECHNOLOGY, INC. | Corporate Officer/Principal | 01.11.2023 | - |
Karriereverlauf von Martin Huber
Ehemalige bekannte Positionen von Martin Huber
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Quantapore, Inc.
 Quantapore, Inc. BiotechnologyHealth Technology Quantapore, Inc. develops nanopore based nucleic acid sequencing technology products. The firm's proprietary DNA sequencing technology is based on an optically labeled nanopore which interacts via energy transfer with a labeled nucleic acid sample. The company was founded by Martin Huber and Sascha C. Dennstedt in 2009 and is headquartered in Menlo Park, CA. | Direktor/Vorstandsmitglied | 01.01.2009 | - |
| Vorstandsvorsitzender | 01.01.2009 | - | |
| Gründer | 01.01.2009 | - |
Ausbildung von Martin Huber
| University of Vienna | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 3 |
| Österreich | 2 |
Operativ
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
| Founder | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NAUTILUS BIOTECHNOLOGY, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Quantapore, Inc.
Quantapore, Inc. BiotechnologyHealth Technology Quantapore, Inc. develops nanopore based nucleic acid sequencing technology products. The firm's proprietary DNA sequencing technology is based on an optically labeled nanopore which interacts via energy transfer with a labeled nucleic acid sample. The company was founded by Martin Huber and Sascha C. Dennstedt in 2009 and is headquartered in Menlo Park, CA. | Health Technology |
- Börse
- Insiders
- Martin Huber
- Erfahrung
